Operation display section of cascade graphical user interface for antibiotic susceptibility testing of constructed microorganisms of electronic device
CN310023800SActive Publication Date: 2026-06-09BECTON DICKINSON & CO
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Designs(China)
- Current Assignee / Owner
- BECTON DICKINSON & CO
- Filing Date
- 2024-07-30
- Publication Date
- 2026-06-09
Smart Images

Figure 000001_ABST
Abstract
1. Name of the product in this design: Operation display unit of a cascaded graphical user interface for microbial antibiotic susceptibility testing of an electronic device. 2. Purpose of this design: An electronic device. 3. The key design features of this product are: the content that the graphical user interface requires protection for. 4. The picture or photo that best illustrates the key design points: Design 1 front view. 5. Design 1 is designated as the basic design. 6. Uses of the graphical user interface: Overall use of the interface: For microorganisms in patient samples, clinicians use the interface to identify drugs that the microorganisms are susceptible to, build cascades for candidate drug families, and create multiple tiers if the microorganisms show resistance to drugs in the previous tier. The part of the interface is the operation display section of the cascaded graphical user interface. The buttons on the left side of the interface allow users to add new cascades and view existing cascades; the two buttons in the upper right corner allow users to delete and save cascades; users can enter the cascade name in the first rectangle from the left at the top, select the biological interpretation group by clicking the second rectangle, and select the style type by clicking the third rectangle; users can select a specific drug by clicking the "Select drug" rectangle in the interface, add a new drug family by clicking the rectangle with the "+" symbol on the right; and add a new cascade by clicking the "+" rectangle at the bottom. After a user clicks the "Select drug" rectangle in the main view of Design 1 to select a drug, the interface changes to Design 1's modified state diagram 1. The user can then click the delete icon to the right of the name to delete the drug. After the user clicks the "Select drug" rectangle below Drug Family 1 in Design 1's modified state diagram 1, the interface changes to Design 1's modified state diagram 2. After the user clicks the rectangle with a "+" symbol in the middle right of Design 1's modified state diagram 2, the interface changes to Design 1's modified state diagram 3. After the user clicks the "Select drug" rectangle below Drug Family 2 in Design 1's modified state diagram 3, the interface changes to Design 1's modified state diagram 4. After the user clicks the rectangle with a "+" symbol in the middle right of Design 1's modified state diagram 4, the interface changes to Design 1's modified state diagram 5. After the user clicks the rectangle with a "+" symbol at the bottom of Design 1's modified state diagram 5 to add a new cascade, the interface changes to Design 1's modified state diagram 6. After the user clicks the "Select" rectangle in the second cascade of Design 1's modified state diagram 6... After selecting a drug using the "drug" rectangle, the interface changes to Design 1, state diagram 7. When the user clicks the rectangle with the "+" symbol at the bottom of Design 1, state diagram 7, to add a new cascade, the interface changes to Design 1, state diagram 8. The change process of Design 2 is the same as Design 1. 7. Other matters to be noted: The dotted line part of the figure is not claimed.
Need to check novelty before this filing date? Find Prior Art